Abstract:Wilson disease is a genetic disorder of the liver characterized by excess accumulation of copper, which is found ubiquitously on earth and normally enters the human body in small amounts via the food chain. Many interesting disease details were published on the mechanistic steps, such as the generation of reactive oxygen species (ROS) and cuproptosis causing a copper dependent cell death. In the liver of patients with Wilson disease, also, increased iron deposits were found that may lead to iron-related ferroptosis responsible for phospholipid peroxidation within membranes of subcellular organelles. All topics are covered in this review article, in addition to the diagnostic and therapeutic issues of Wilson disease. Excess Cu2+ primarily leads to the generation of reactive oxygen species (ROS), as evidenced by early experimental studies exemplified with the detection of hydroxyl radical formation using the electron spin resonance (ESR) spin-trapping method. The generation of ROS products follows the principles of the Haber–Weiss reaction and the subsequent Fenton reaction leading to copper-related cuproptosis, and is thereby closely connected with ROS. Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein. As a result, disturbed cellular homeostasis of copper prevails within the liver. Released from the liver cells due to limited storage capacity, the toxic copper enters the circulation and arrives at other organs, causing local accumulation and cell injury. This explains why copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia, renal tubular dysfunction, Kayser–Fleischer corneal rings, cardiomyopathy, cardiac arrhythmias, rhabdomyolysis, osteoporosis, osteomalacia, arthritis, and arthralgia. In addition, Coombs-negative hemolytic anemia is a key feature of Wilson disease with undetectable serum haptoglobin. The modified Leipzig Scoring System helps diagnose Wilson disease. Patients with Wilson disease are well=treated first-line with copper chelators like D-penicillamine that facilitate the removal of circulating copper bound to albumin and increase in urinary copper excretion. Early chelation therapy improves prognosis. Liver transplantation is an option viewed as ultima ratio in end-stage liver disease with untreatable complications or acute liver failure. Liver transplantation finally may thus be a life-saving approach and curative treatment of the disease by replacing the hepatic gene mutation. In conclusion, Wilson disease is a multifaceted genetic disease representing a molecular and clinical challenge.

Copper Exerts Cytotoxicity Through Inhibition of Iron-Sulfur Cluster Biogenesis on ISCA1/ISCA2/ISCU Assembly Proteins

The molecular mechanisms of copper metabolism and its roles in human diseases

Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update

Identification of High-Copper-responsive Target Pathways in Atp7b Knockout Mouse Liver by GSEA on Microarray Data Sets.

Deadly excess copper

Systemic deletion of Atp7b modifies the hepatocytes’ response to copper overload in the mouse models of Wilson disease

A new Caenorhabditis elegans model to study copper toxicity in Wilson disease

Copper impairs the intestinal barrier integrity in Wilson disease

Anaerobic Copper Toxicity and Iron-Sulfur Cluster Biogenesis in Escherichia Coli.

The Discrepancy Between the Absence of Copper Deposition and the Presence of Neuronal Damage in the Brain of Atp7b(-/-) Mice.

Copper homeostasis and cuproptosis in health and disease

Aberrant copper metabolism and hepatic inflammation cause neurological manifestations in a mouse model of Wilson's disease

Defective Roles of Atp7b Missense Mutations in Cellular Copper Tolerance and Copper Excretion

The physiological and pathophysiological roles of copper in the nervous system

The possible association of mitochondrial fusion and fission in copper deficiency-induced oxidative damage and mitochondrial dysfunction of the heart

Copper exposure induces inflammation and PANoptosis through the TLR4/NF-κB signaling pathway, leading to testicular damage and impaired spermatogenesis in Wilson disease

Copper deficiency and heart disease: molecular basis, recent advances and current concepts

In vitro assessment of copper-induced toxicity in the human hepatoma line, Hep G2

The Role of Copper Overload in Modulating Neuropsychiatric Symptoms

Congenital cataract, muscular hypotonia, developmental delay and sensorineural hearing loss associated with a defect in copper metabolism

1H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson's disease